AMICUS THERAPEUTICS, INC. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Amicus Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q3 2024.
  • Amicus Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $18.7M, a 11.6% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $18.7M -$2.45M -11.6% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $17.4M -$1.69M -8.86% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $17.7M -$2.52M -12.5% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $18.6M -$689K -3.58% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $21.1M +$3.26M +18.2% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $19M +$1M +5.56% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $20.2M -$5.02M -19.9% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $19.2M -$5.19M -21.2% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $17.9M -$4.21M -19% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $18M -$3.16M -14.9% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $25.2M +$4.65M +22.6% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $24.4M +$5.33M +27.9% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $22.1M -$4.38M -16.5% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $21.2M -$4.68M -18.1% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $20.5M -$8.88M -30.2% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $19.1M -$9.22M -32.6% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $26.5M +$12.1M +84.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $25.9M +$13.8M +115% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $29.4M +$18.1M +161% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $28.3M +$21.6M +324% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $14.4M +$8.25M +135% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $12M +$6.12M +103% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $11.3M +$5.67M +101% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $6.68M +$1.48M +28.5% Dec 31, 2018 10-K 2020-03-02
Q3 2018 $6.1M +$1.88M +44.6% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 $5.92M +$2.91M +96.6% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $5.59M +$2.66M +90.7% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $5.2M +$2.73M +111% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $4.22M +$2.43M +136% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $3.01M +$1.35M +81.6% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $2.93M +$1.45M +97.6% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $2.47M +$1.36M +123% Dec 31, 2016 10-K 2018-03-01
Q3 2016 $1.79M +$806K +82.1% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $1.66M +$733K +79.3% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $1.48M +$592K +66.4% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 $1.11M +$606K +121% Dec 31, 2015 10-K/A 2017-03-03
Q3 2015 $982K +$474K +93.3% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $924K +$409K +79.4% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $892K +$346K +63.4% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $502K -$50K -9.06% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $508K +$66K +14.9% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $515K +$73K +16.5% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $546K +$104K +23.5% Mar 31, 2014 10-Q 2014-05-05
Q4 2013 $552K +$110K +24.9% Dec 31, 2013 10-K 2015-03-03
Q3 2013 $442K $0 0% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $442K $0 0% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 $442K $0 0% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $442K -$267K -37.7% Dec 31, 2012 10-K 2014-03-03
Q3 2012 $442K -$272K -38.1% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $442K +$175K +65.5% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 $442K Mar 31, 2012 10-Q 2012-05-11
Q4 2011 $709K +$442K +166% Dec 31, 2011 10-K 2013-03-13
Q3 2011 $714K Sep 30, 2011 10-Q 2011-11-02
Q2 2011 $267K Jun 30, 2011 10-Q 2011-08-11
Q4 2010 $267K Dec 31, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.